Unknown

Dataset Information

0

Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline.


ABSTRACT: Drug isomers may differ in their proarrhythmia risk. An interesting example is the drug sotalol, an antiarrhythmic drug comprising d- and l- enantiomers that both block the hERG cardiac potassium channel and confer differing degrees of proarrhythmic risk. We developed a multi-scale in silico pipeline focusing on hERG channel - drug interactions and used it to probe and predict the mechanisms of pro-arrhythmia risks of the two enantiomers of sotalol. Molecular dynamics (MD) simulations predicted comparable hERG channel binding affinities for d- and l-sotalol, which were validated with electrophysiology experiments. MD derived thermodynamic and kinetic parameters were used to build multi-scale functional computational models of cardiac electrophysiology at the cell and tissue scales. Functional models were used to predict inactivated state binding affinities to recapitulate electrocardiogram (ECG) QT interval prolongation observed in clinical data. Our study demonstrates how modeling and simulation can be applied to predict drug effects from the atom to the rhythm for dl-sotalol and also increased proarrhythmia proclivity of d- vs. l-sotalol when accounting for stereospecific beta-adrenergic receptor blocking.

SUBMITTER: DeMarco KR 

PROVIDER: S-EPMC8906354 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline.

DeMarco Kevin R KR   Yang Pei-Chi PC   Singh Vikrant V   Furutani Kazuharu K   Dawson John R D JRD   Jeng Mao-Tsuen MT   Fettinger James C JC   Bekker Slava S   Ngo Van A VA   Noskov Sergei Y SY   Yarov-Yarovoy Vladimir V   Sack Jon T JT   Wulff Heike H   Clancy Colleen E CE   Vorobyov Igor I  

Journal of molecular and cellular cardiology 20210529


Drug isomers may differ in their proarrhythmia risk. An interesting example is the drug sotalol, an antiarrhythmic drug comprising d- and l- enantiomers that both block the hERG cardiac potassium channel and confer differing degrees of proarrhythmic risk. We developed a multi-scale in silico pipeline focusing on hERG channel - drug interactions and used it to probe and predict the mechanisms of pro-arrhythmia risks of the two enantiomers of sotalol. Molecular dynamics (MD) simulations predicted  ...[more]

Similar Datasets

| S-EPMC9048659 | biostudies-literature
| S-EPMC9489646 | biostudies-literature
| S-EPMC10120856 | biostudies-literature
| S-EPMC7921311 | biostudies-literature
| S-EPMC4281228 | biostudies-literature
| S-EPMC6707190 | biostudies-literature
| S-EPMC7597207 | biostudies-literature
| S-EPMC10627799 | biostudies-literature
| S-EPMC9228121 | biostudies-literature
| S-EPMC3560535 | biostudies-literature